MedPath

The comparison of analgesic effect sufentanil-remimazolam vs remifentanil-remimazolam on robotic prostatectomy

Not Applicable
Conditions
Diseases of the genitourinary system
Registration Number
KCT0009049
Lead Sponsor
Dong-A University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
Male
Target Recruitment
62
Inclusion Criteria

Among patients aged 19 years or older who underwent robotic prostatectomy performed in the central operating room of our hospital from IRB approval until October 2024, 62 patients with ASA score I, II, or III are eligible. 31 people in each group are randomly assigned.

Exclusion Criteria

? emergency cases
? intraoperative development of hemodynamic instability
? massive hemorrhage that required rescue management
? severe nausea and vomiting that required withholding an additional IV opioid
? Refusal to participate in the study

Study & Design

Study Type
Observational Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Time from completion of surgery to requesting the first painkiller injection in the recovery room
Secondary Outcome Measures
NameTimeMethod
1. NRS (Numeric rating scale) of pain immediately after surgery, 10 minutes, and 20 minutes later Visual analog scale (VAS) comparison of pain 1, 2, 6, 12, and 24 hours after surgery 2. Values of blood pressure, heart rate, and BIS during surgery 3. Total amount of painkillers used after completion of surgery 4. Time from completion of surgery to extubation, time from completion of surgery to recovery of orientation, time to open eyes after completion of surgery, time to spontaneous breathing after completion of surgery 5. Total anesthesia time, total amount of anesthetic used, number of days of hospital stay 6. Complications occurring after surgery
© Copyright 2025. All Rights Reserved by MedPath